Stock comparison
Moderna, Inc. is 15.3x more valuable than MESOBLAST LTD by market capitalization ($30.38 B vs $1.99 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRNA is larger
Moderna, Inc. is 15.3x more valuable than MESOBLAST LTD by market capitalization ($30.38 B vs $1.99 B).
Market value leader
MRNA
Moderna, Inc. is 15.3x more valuable than MESOBLAST LTD by market capitalization ($30.38 B vs $1.99 B).
| Metric | MESO | MRNA |
|---|---|---|
| Market cap | $1.99 B | $30.38 B |
| US-listed rank | #2144 | #461 |
| Revenue (latest FY) | - | $1.94B |
| Net income (latest FY) | - | -$2.82B |
| Net margin | - | -145.2% |
| P/E (trailing FY) | - | - |
| SEC filings | 576 | 1,447 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Moderna, Inc. is 15.3x more valuable than MESOBLAST LTD by market capitalization ($30.38 B vs $1.99 B).
Full pages: MESOBLAST LTD and Moderna, Inc., or browse the full rankings.